19 results
425
SLXN
Biomotion Sciences Ordinary Shares
25 Jul 24
Business combination disclosure
4:05pm
run - in Phase 2 expanded Phase 3 21 World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY
425
MACA
Moringa Acquisition Corp
25 Jul 24
Business combination disclosure
4:05pm
World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY Winthrop Rockefeller Endowed Chair
DEFM14A
MACA
Moringa Acquisition Corp
17 Jul 24
Proxy related to merger
9:13am
. Brachfeld qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management
PRE 14A
2ags9u y0jt9u7gwq3
15 Dec 22
Preliminary proxy
5:18pm
10-K
tp3a93ae4nbk
31 Mar 21
Annual report
5:15pm
8-K
EX-10.7
mcbu c8odab
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.8
f1k 8l99j0u
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.12
vcq bhz10bvadwht
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.10
dwtdg29alg2vyhs0m
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.6
livfh5g
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.9
j6jm1womee5bhg
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.11
oa9 eabow4
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
424B4
amks3j2pdj
17 Feb 21
Prospectus supplement with pricing info
11:53am
S-1
t3az9
1 Feb 21
IPO registration
4:12pm
S-1
EX-10.7
tpf2yeo5gdy wvja1my
1 Feb 21
IPO registration
4:12pm
DRS
vaq 12ddhn9wh
22 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next